We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Shorter Hospital Stays Help HCA Handle More Patient Demand?
Read MoreHide Full Article
Key Takeaways
HCA's admissions rose 2.4%, while average stays fell to 4.643 days in the second quarter of 2026.
HCA's patient days increased just 0.6%, well below admission growth, while occupancy improved to 72.7%.
HCA plans more than $7 billion in capital spending, including 1,000 to 1,200 additional inpatient beds.
HCA Healthcare, Inc. (HCA - Free Report) is seeing higher patient volumes while patients are spending slightly less time in its hospitals. This combination could help the company use existing capacity more effectively as it continues to expand its network. In the second quarter of 2026, reported admissions increased 2.4% year over year to nearly 580,000. Same-facility admissions rose 2.5%, while same-facility emergency room visits advanced 3.6%.
At the same time, the average length of stay declined to 4.643 days from 4.726 days a year earlier. Occupancy improved to 72.7% from 72.0%, even as the average length of stay declined. This shows that HCA accommodated faster admission growth without a comparable increase in patient days. Patient days increased just 0.6%, considerably slower than admission growth.
The trend could become increasingly relevant as demand grows across the company’s markets and it continues investing in inpatient beds and emergency room capacity. HCA has approved more than $7 billion of capital expenditures expected to come online over the next three years, including 1,000 to 1,200 additional inpatient beds.
Still, shorter stays do not automatically translate into better operating performance. Service mix can influence the metric, while lower surgical volumes remain a consideration. For HCA, the key will be maintaining admission growth while managing hospital capacity without compromising care delivery. If that balance persists, shorter stays could give the company additional flexibility as patient volumes grow.
How Do Peers Compare?
HCA’s Medical peers, including Tenet Healthcare Corporation (THC - Free Report) and Universal Health Services, Inc. (UHS - Free Report) , are also seeing steady hospital demand.
Tenet reported a 2.6% increase in same-hospital adjusted admissions in the second quarter of 2026, while emergency room visits rose 2%. THC’s hospital surgeries declined 0.7%, but net patient service revenue per adjusted admission increased 3.3%, supporting a 22.3% rise in hospital adjusted EBITDA to $762 million.
Universal Health’s same-facility acute-care adjusted admissions increased 2.9%, while adjusted patient days rose 3.1%. Net revenue per adjusted admission advanced 3%, helping acute-care revenues grow 8.2%. UHS saw patient-day growth broadly track admissions, while HCA’s patient-day growth remained well below its admission growth.
HCA’s Price Performance, Valuation & Estimates
Shares of HCA Healthcare have gained 3.4% over the past year compared with the industry's 15.3% growth over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, HCA trades at a forward price-to-earnings ratio of 13.91, down from the industry average of 16.67. HCA carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HCA’s 2026 earnings is pegged at $29.42 per share, implying a 4.3% jump from the year-ago period’s level.
View the Zacks #1 Rank List
Image: Bigstock
Can Shorter Hospital Stays Help HCA Handle More Patient Demand?
Key Takeaways
HCA Healthcare, Inc. (HCA - Free Report) is seeing higher patient volumes while patients are spending slightly less time in its hospitals. This combination could help the company use existing capacity more effectively as it continues to expand its network. In the second quarter of 2026, reported admissions increased 2.4% year over year to nearly 580,000. Same-facility admissions rose 2.5%, while same-facility emergency room visits advanced 3.6%.
At the same time, the average length of stay declined to 4.643 days from 4.726 days a year earlier. Occupancy improved to 72.7% from 72.0%, even as the average length of stay declined. This shows that HCA accommodated faster admission growth without a comparable increase in patient days. Patient days increased just 0.6%, considerably slower than admission growth.
The trend could become increasingly relevant as demand grows across the company’s markets and it continues investing in inpatient beds and emergency room capacity. HCA has approved more than $7 billion of capital expenditures expected to come online over the next three years, including 1,000 to 1,200 additional inpatient beds.
Still, shorter stays do not automatically translate into better operating performance. Service mix can influence the metric, while lower surgical volumes remain a consideration. For HCA, the key will be maintaining admission growth while managing hospital capacity without compromising care delivery. If that balance persists, shorter stays could give the company additional flexibility as patient volumes grow.
How Do Peers Compare?
HCA’s Medical peers, including Tenet Healthcare Corporation (THC - Free Report) and Universal Health Services, Inc. (UHS - Free Report) , are also seeing steady hospital demand.
Tenet reported a 2.6% increase in same-hospital adjusted admissions in the second quarter of 2026, while emergency room visits rose 2%. THC’s hospital surgeries declined 0.7%, but net patient service revenue per adjusted admission increased 3.3%, supporting a 22.3% rise in hospital adjusted EBITDA to $762 million.
Universal Health’s same-facility acute-care adjusted admissions increased 2.9%, while adjusted patient days rose 3.1%. Net revenue per adjusted admission advanced 3%, helping acute-care revenues grow 8.2%. UHS saw patient-day growth broadly track admissions, while HCA’s patient-day growth remained well below its admission growth.
HCA’s Price Performance, Valuation & Estimates
Shares of HCA Healthcare have gained 3.4% over the past year compared with the industry's 15.3% growth over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, HCA trades at a forward price-to-earnings ratio of 13.91, down from the industry average of 16.67. HCA carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HCA’s 2026 earnings is pegged at $29.42 per share, implying a 4.3% jump from the year-ago period’s level.
Image Source: Zacks Investment Research
HCA currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.